Organization: Oncology Drugs Advisory Committee

Inex cuts workforce, reduces burn rate

Inex Pharmaceuticals Corp, Vancouver, is slashing its workforce and cutting back on its planned pipeline activities following the rejection by US regulatory authorities of its application for accelerated approval of Marqibo, the firm’s lead anticancer drug. The Oncology Drugs Advisory Committee of the US Food and Drug Administration voted unanimously against accelerated approval for Marqibo,…